Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous tartrate is a chemical compound and the iron(II) salt of tartaric acid. Historically used as a "steel medicine," it was commonly prescribed during the 19th and early 20th centuries as a stomachic and tonic. Its primary medical use was for the treatment of anemia due to its role as an iron supplement. The mechanism of action involves providing bioavailable iron necessary for hemoglobin synthesis and red blood cell production. Ferrous tartrate is classified as a small molecule within the group of organic acids known as beta hydroxy acids and derivatives[1][4][5]. It is now considered largely obsolete in modern clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous tartrate.